Showing results (1011-1020 of 3,472) with videos related to

Sort By:
Pageof 348
Molecules (Basel, Switzerland)|May 13, 2023
Chemistry Related to the Catalytic Cycle of the Antioxidant EbselenKai N Sands, Austin L Burman, Esther Ansah-Asamoah, et al.
The Ulster Medical Journal|March 28, 2018
Dystrophin Exon 29 Nonsense Mutations Cause a Variably Mild PhenotypeRebecca S Moore, Sandya Tirupathi, Brian Herron, et al.
The Journal of Biological Chemistry|July 20, 2006
Loss of N-linked glycosylation reduces urea transporter UT-A1 response to vasopressinGuangping Chen, Otto Fröhlich, Yuan Yang, et al.
Journal of Strength and Conditioning Research|May 29, 2007
Validation of instrumentation to monitor dynamic performance of olympic weightliftersAdam J Bruenger, Sarah L Smith, William A Sands, et al.
Journal of Clinical Gastroenterology|August 19, 2006
Variation in severity assessment and initial mesalamine dose selection for ulcerative colitis in community practiceBruce E Sands, Karl M Kilgore, Richard S Bloomfeld, et al.
The American Surgeon|July 29, 2004
Primary malignant melanoma of the right colonShmuel Avital, Rita L Romaguera, Laurance Sands, et al.
Gut|July 13, 2004
Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's diseaseD G Forcione, M J Rosen, J B Kisiel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 6, 2004
What explains differences between dementia patients' and their caregivers' ratings of patients' quality of life?Laura P Sands, Patricia Ferreira, Anita L Stewart, et al.
Clinical Pharmacy|February 1, 1992
Effect of phenylpropanolamine hydrochloride on blood pressure in Korean patients with hypertension controlled by hydrochlorothiazideC D Sands, K M Jung, D W Jones, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 12, 2004
Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II StudyBruce E Sands, Marion A Blank, Kam Patel, et al.
Pageof 348